Ms. Suzanne McGurn joined CADTH in July 2020 as its President and Chief Executive Officer. She brings to the role a deep understanding of the complex issues surrounding the management of pharmaceuticals, medical devices, and clinical interventions in Canadian health systems.
Prior to joining CADTH, Ms. McGurn’s distinguished career spanned clinical practice, patient support, and senior roles in government. Within the Ontario Ministry of Health, she served as the Assistant Deputy Minister of the Drugs and Devices Division and the Executive Officer of the Ontario Public Drug Programs. She also led the implementation of the pan-Canadian Pharmaceutical Alliance and served as its first chair.
Ms. McGurn holds both a Bachelor of Nursing Sciences and a Master of Public Administration from Queen’s University.
Agenda: Day 1 Oct 5, 2020
1:00 pm
1:00 pm
PANEL DISCUSSION
IS RWE TRULY THE PANCEA WE ALL THINK IT IS/WILL BE?
RWE (real world evidence) has been hailed by many as the ‘magic bullet’ the industry – and Canadians overall – have been looking for it to speed up access to market for new medicines. But is it? Bring back learnings from other jurisdictions such as the UK to optimize your upcoming PLAs.
Agenda: Day 2 Oct 6, 2020
